IDH1 and IDH2 Driven Intrahepatic Cholangiocarcinoma (IHCC): A comprehensive genomic and immune profiling study.

被引：8
|
作者：
Makawita, Shalini
Borad, Mitesh J.
Carapeto, Fernando
Kwong, Lawrence
Bekaii-Saab, Tanios S.
Murugesan, Karthikeyan
Ross, Jeffrey S.
Danziger, Natalie
Israel, Mason A.
McGregor, Kimberly
Janku, Filip
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
[4] Fdn Med Inc, Cambridge, MA USA
[5] Fdn Med, Cambridge, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4009
引用
收藏
页数：3
相关论文
共 50 条
  • [21] IDH1 and IDH2: Not Your Typical Oncogenes
    Reitman, Zachary J.
    Parsons, D. Williams
    Yan, Hai
    CANCER CELL, 2010, 17 (03) : 215 - 216
  • [22] IDH1 AND IDH2 MUTATIONS AND THEIR CORRELATIONS IN GLIOMAS
    Mellai, M.
    Monzeglio, O.
    Piazzi, A.
    Giordano, M.
    Andreoli, E.
    Cassoni, P.
    Schiffer, D.
    NEURO-ONCOLOGY, 2010, 12 : 32 - 32
  • [23] Targeting IDH1/IDH2 mutations in gliomas
    de la Fuente, Macarena I.
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (06) : 787 - 793
  • [24] IDH1 and IDH2 Mutations in Gliomas REPLY
    Reitman, Zachary
    Yan, Hai
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2249 - 2249
  • [25] Metabolism of glioma and IDH1/IDH2 mutations
    Rossetto, M.
    Ciccarino, P.
    Boisselier, B.
    Labussiere, M.
    Sanson, M.
    REVUE NEUROLOGIQUE, 2011, 167 (10) : 699 - 703
  • [26] METABOLOMIC PROFILING OF A GLIOMA CELL LINE EXPRESSING IDH1 AND IDH2 MUTANTS
    Reitman, Zachary J.
    Jin, Genglin
    Karoly, Edward D.
    Spasojevic, Ivan
    Yang, Jian
    Kinzler, Kenneth W.
    He, Yiping
    Bigner, Darell D.
    Vogelstein, Bert
    Yan, Hai
    NEURO-ONCOLOGY, 2011, 13 : I22 - I23
  • [27] DIFFERENCES IN THE IMMUNE MICROENVIRONMENT OF GLIOMAS HARBORING IDH2 VERSUS IDH1 MUTATIONS
    Ostrom, Quinn
    Xiu, Joanne
    Lopez, Giselle
    Sumrall, Ashley
    Aulakh, Sonikpreet
    Glantz, Michael
    Pan, Edward
    Khasraw, Mustafa
    Ashley, David M.
    Walsh, Kyle
    NEURO-ONCOLOGY, 2021, 23 : 13 - 14
  • [28] IDH1 reactivity and mosaic IDH1 or IDH2 somatic mutations in solitary enchondroma and enchondromatosis
    Saiji, E.
    Biderbost, C. Cerato
    Berczy, M.
    Rougemont, A. -L.
    VIRCHOWS ARCHIV, 2015, 467 : S167 - S167
  • [29] Mutational analysis for IDH1 and IDH2 in pediatric leukemia
    Hiwatari, Mitsuteru
    Takita, Junko
    Nishimura, Riki
    Okubo, Jun
    Oki, Kentaro
    Sanada, Masashi
    Sotomatsu, Manabu
    Kikuchi, Akira
    Igarashi, Takashi
    Hayashi, Yasuhide
    Ogawa, Seishi
    CANCER RESEARCH, 2012, 72
  • [30] The clinical use of IDH1 and IDH2 mutations in gliomas
    Picca, Alberto
    Berzero, Giulia
    Di Stefano, Anna Luisa
    Sanson, Marc
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2018, 18 (12) : 1041 - 1051
12345